Analyst Recommendations

1.80 -0.11(-5.76%)09/16/2024
Esperion Therapeutics Inc. (ESPR)


2024: Total Recommendations Consensus
To Grade# of Recommendations
Buy13
Underperform1

5 records were shown. To view all data, Upgrade to PRO plan with only $1


Upgrades & Downgrades